Eddie Thara is an Oncology physician. OpenAlex indexes 24 publications with 250 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11480 Brookshire Ave
Suite 309
Downey, CA 902415025
Telephone
562-869-1201Registry record last updated 19 Nov 2018.
Industry payments
94 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202515 payments
- PFIZER INC.Program year202517 payments
- Novartis Pharmaceuticals CorporationProgram year202519 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
36.9%RANK Ligand Inhibitor36.6%Denosumab100%Part B, office-administered≥17 patientsXanthine oxidase inhibitor0.2%Allopurinol100%Part D<11 patients+ 1 more class in this area
Sensory organs
24.7%Corticosteroid24.7%Dexamethasone sodium phosphate96%Dexamethasone Sodium Phosphate3%Dexamethasone1%Part D + Part B≥32 patientsBlood & clotting
19.4%Iron, parenteral preparations18.8%Ferric derisomaltose100%Part B, office-administered≥14 patientsFactor Xa inhibitor0.6%Eliquis100%Part D≥28 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”